Am J Transplant, Volume 19, Suppl 3 Archives - Page 22 of 214 - ATC Abstracts

2019 American Transplant Congress
The Impact of Early Subtherapeutic Tacrolimus Troughs with Alemtuzumab Induction
L. Bowman¹, E. Yanqui¹, C. Truong¹, R. Baliga², A. Brueckner¹
¹Tampa General Hospital, Tampa, FL, ²Florida Kidney Physicians, Tampa, FL
*Purpose: Prior studies in kidney transplant recipients (KTR) have demonstrated that lower tacrolimus (TAC) exposure during the first week is associated with an increased incidence…
2019 American Transplant Congress
Effect of Severe Diarrhea on Kidney Transplant Outcomes
J. Kim, J. Ha, Y. Kim, S. Han
Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: In addition to immunological complications, non-immunological events should be considered following kidney transplantation. Among them, diarrhea is the most common gastrointestinal complication, but its…
2019 American Transplant Congress
Rituximab Protects against Development of Atherosclerotic Cardiovascular Disease after Kidney Transplantation, a Propensity Matched Analysis
D. Kim, J. Lee, J. Lee, B. Kim, M. Kim, S. Soon Il, Y. Kim, K. Huh, S. Kim, D. Joo, K. In, E. Kim
Severance hospital, Seoul, Korea, Republic of
*Purpose: Recent studies have implicated B cells in atherosclerosis and have verified the atheroprotective effect of rituximab. We sought to explore the effects of rituximab…
2019 American Transplant Congress
Growth and Function of En Bloc Kidney Transplantation: A Single-Center Experience
H. Mo¹, J. Ha¹, A. Han¹, S. Min¹, S. Min¹, S. Ahn¹, I. Ha², H. Kang², S. Kim³
¹Department of surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ²Pediatric Nephrology, Seoul National University Hospital, Seoul, Korea, Republic of, ³Department of surgery, Myongji Hospital, Seoul, Korea, Republic of
*Purpose: To overcome organ shortage, using en bloc renal allografts is widely accepted strategy. In this study we review the results of en bloc kidney…
2019 American Transplant Congress
The Response to Human Papillomavirus Vaccination in Pediatric Patients before and after Kidney Transplantation
C. Nailescu¹, R. D. Nelson², K. Twombley³, P. S. Verghese⁴, A. S. Chishti⁵, M. Mills⁶, J. E. Slaven⁷, J. D. Mahan⁸, M. L. Shew¹
¹Riley Hospital for Children, Indianapolis, IN, ²Primary Children’s Hospital, Salt Lake City, UT, ³MUSC Children’s Hospital, Charleston, SC, ⁴Children’s Hospitals and Clinics of Minnesota, Minneapolis, MN, ⁵Kentucky Children’s Hospital, Lexington, KY, ⁶C.S. Mott Children’s Hospital, Ann Arbor, MI, ⁷Indiana University, Indianapolis, IN, ⁸Nationwide Children’s Hospital, Columbus, OH
*Purpose: Kidney transplant (KT) recipients have an increased incidence of malignancies, including Human Papillomavirus (HPV)-associated cancers. Thus, HPV vaccines may have an important role in…
2019 American Transplant Congress
Immunosuppression Reduction after Diagnosis of Sustained BK Viremia and the Risk of Allograft Rejection, Allograft Loss and Mortality
F. A. Al Dhufairi¹, M. Shokoohi², A. M. Jevnikar¹, A. A. House¹, D. Kumar³, S. M. Hosseini-Moghaddam¹
¹Department of Medicine, Western University, London Health Sciences Centre, London, ON, Canada, ²Epidemiology and Biostatistics, Western University, London, ON, Canada, ³Department of Medicine, University Of Toronto, University Health Network, Toronto, ON, Canada
*Purpose: BK viremia increases the risk of allograft loss after renal transplantation. Current guidelines recommend immunosuppression reduction (IsR) after the diagnosis of BK viremia. The…
2019 American Transplant Congress
BK Virus Infection among Kidney Transplant Recipients with High Immunological Risk and Strong Immunosupression
G. Ledesma, M. O. Lopez, G. Carreño, M. J. Santana, M. A. Vaca, E. Gonzalez, C. Jimenez
Nephrology, Hospital Universitario La Paz, Madrid, Spain
*Purpose: BK virus infection represents one of the main viral infections within the first year after kidney transplantation, closely linked to the degree of immunosupresion.…
2019 American Transplant Congress
Identifying a Clinically Relevant Cut-Off for Height That is Associated with a Higher Risk of Waitlist Mortality in Liver Transplant Candidates
J. Ge, J. C. Lai
University of California - San Francisco, San Francisco, CA
*Purpose: We have previously demonstrated that candidate height explains a substantial proportion of sex-based disparity in waitlist (WL) mortality among liver transplant (LT) candidates. To…
2019 American Transplant Congress
The Impact of Share 35 on Living Donor Liver Transplant Utilization in the United States: Analysis of UNOS Data
H. J. Braun, J. L. Dodge, J. D. Grab, R. Hirose, P. G. Stock, N. L. Ascher
University of California, San Francisco, San Francisco, CA
*Purpose: In 2013, the Share 35 policy was implemented in the United States (US) to improve timely organ allocation to high MELD patients awaiting liver…
2019 American Transplant Congress
Metabolic Liver Transplant: A Single Cooperative 2002-2017
N. Yazigi¹, K. Chapman²
¹Transplantation, MedStar Georgetown University Hospital, Washigton, DC, ²Transplantation, Children's National Rare Disease Institute, Washington, DC
*Purpose: Liver transplant (LT) can increase quality and quantity of life for patients with inherited metabolic diseases (IMDs) who suffer severe and unpredictable complications despite…